President Trump touted his efforts in “taking on the big pharmaceutical companies” over drug pricing in his State of the Union address on 4 February but stopped short of announcing any new Administration initiatives.
Trump spent just a few minutes of his wide-ranging, hour and twenty-minute speech on drug pricing. And despite speculation that...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?